ESC Guidelines: CRT Gets Nod For Mild Symptoms, But Not Asymptomatic HF
This article was originally published in The Gray Sheet
Executive Summary
New European 1guidelines provide strong support for extending cardiac resychronization therapy to a broader set of heart failure patients, but not quite the same population as an FDA panel recently recommended in the U.S